This piece reports on proposals from the AIPM to the Hungarian government aimed at boosting the pharmaceutical sector's competitiveness. Recommendations include simplifying the drug approval process, establishing patient registries, and monitoring therapy effectiveness. The article also notes that innovative pharmaceutical companies now finance over half of the national drug budget, up from 25% previously.